Evidence check: Stuhlprobe in the context of weight loss

Stool sample analysis for weight loss is often marketed by direct-to-consumer (DTC) companies like MyBody-X, but the scientific evidence is weak. Stool tests can characterize the gut microbiome, but the link between specific bacterial profiles and weight loss is complex, highly individual, and not yet well understood. Most studies are observational, showing associations rather than causation, and lack standardized protocols to translate microbiome data into actionable dietary advice. Results from consumer tests are often not reproducible and are confounded by diet, medications, and lifestyle. MyBody-X and similar providers rely heavily on marketing claims that overstate the evidence. A responsible approach would be to use stool tests only within clinical research or under medical supervision, not as a standalone weight loss tool. Caveat: Without clinical validation, such tests can mislead consumers, leading to unnecessary expense or false expectations.